Overview

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the safety and tolerability and to determine the Pharmacokinetic and Pharmacodynamic(PK/PD) of ascending multiple oral dose of BR-A-657 in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Collaborator:
Covance